FATE Historical Earnings image   This FATE historical earnings page last updated 11/7/2022
FATE Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202211/3/20220.01B
Q2 20228/3/20220.02B
Q1 20225/4/20220.02B
Q4 20212/28/20220.02B
Q3 202111/4/20210.01B
Q2 20218/4/20210.01B
Q1 20215/5/20210.01B
Q4 20202/24/20210.02B
Q3 202011/5/20200.01B
Q2 20208/5/20200.01B
Q1 20205/11/20200.00B
Q4 20193/2/20200.00B
Q3 201911/5/20190.00B
Q2 20198/6/20190.00B
Q1 20195/7/20190.00B
Q4 20183/5/20191.66M
Q3 201811/1/20181.03M
Q2 20188/6/20181.03M
Q1 20185/10/20181.03M
Q4 20173/5/20181.03M
Q3 201711/1/20171.03M
Q2 20178/14/20171.03M
Q1 20175/15/20171.03M
Q4 20163/16/20171.03M
Q3 201611/7/20161.03M
Q2 20168/8/20161.03M
Q1 20165/9/20161.32M
Q4 20153/3/20161.08M
Q3 201511/3/20151.03M
Q2 20158/5/2015329000
Q1 20155/7/2015NA
Q4 20143/12/2015NA
Q3 201411/11/2014NA
Q2 20148/12/2014NA
Q1 20145/13/2014NA
Q4 20133/17/2014NA
Q3 201311/13/2013209000
FATE Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202211/3/2022-0.860
Q2 20228/3/2022-0.790
Q1 20225/4/2022-0.680
Q4 20212/28/2022-0.720
Q3 202111/4/2021-0.450
Q2 20218/4/2021-0.580
Q1 20215/5/2021-0.480
Q4 20202/24/2021-0.610
Q3 202011/5/2020-0.680
Q2 20208/5/2020-0.350
Q1 20205/11/2020-0.440
Q4 20193/2/2020-0.370
Q3 201911/5/2019-0.400
Q2 20198/6/2019-0.360
Q1 20195/7/2019-0.300
Q4 20183/5/2019-0.25
Q3 201811/1/2018-0.31
Q2 20188/6/2018-0.37
Q1 20185/10/2018-0.27
Q4 20173/5/2018-0.29
Q3 201711/1/2017-0.26
Q2 20178/14/2017-0.23
Q1 20175/15/2017-0.24
Q4 20163/16/2017-0.21
Q3 201611/7/2016-0.27
Q2 20168/8/2016-0.29
Q1 20165/9/2016-0.29
Q4 20153/3/2016-0.26
Q3 201511/3/2015-0.24
Q2 20158/5/2015-0.33
Q1 20155/7/2015-0.38
Q4 20143/12/2015-0.3
Q3 201411/11/2014-0.32
Q2 20148/12/2014-0.3
Q1 20145/13/2014-0.34
Q4 20133/17/2014-0.29
Q3 201311/13/2013-4.81
Quotes delayed 20 minutes

Email EnvelopeFree FATE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Fate Therapeutics (FATE) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

FBIO Historical Earnings
FBRX Historical Earnings
FDMT Historical Earnings
FEMY Historical Earnings
FGEN Historical Earnings
FHTX Historical Earnings
FIXX Historical Earnings
FLDM Historical Earnings
FLGT Historical Earnings
FLXN Historical Earnings
What was the record high FATE historical earnings result?
In terms of earnings or revenue, what is the best FATE historical earnings result that Fate Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest FATE historical earnings result was set in Q4 2016, when Fate Therapeutics posted results of -0.21/share. The most successful revenue quarter within our data set was Q2 2022 when Fate Therapeutics reported revenue of 0.02B.

What was the lowest Fate Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest FATE has reported, and when?

✔️Accepted answer: Within our data set, the lowest FATE historical earnings result was set in Q3 2013, when Fate Therapeutics posted results of -4.81/share. The smallest revenue quarter within our data set was Q1 2015 when Fate Therapeutics reported revenue of NA.

On this page we presented the FATE historical earnings date information for Fate Therapeutics. Reviewing that FATE Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2016, when FATE posted gaap of -0.21/share. Meanwhile the lowest FATE historical earnings result was in Q3 2013, when FATE posted gaap of -4.81/share. Moving to Fate Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when FATE reported 0.02B in revenue, while the smallest revenue quarter was Q1 2015 when FATE reported NA in revenue.

For self directed investors doing their due diligence on FATE or any other given stock, their research can benefit from looking into all of the Fate Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Fate Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for FATE. Thanks for visiting, and the next time you need to research FATE historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: BCX Next Dividend Date, PINS Historical PE Ratio, NAUH Historical Stock Prices.

 

FATE Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.